首页> 中文期刊>中华眼底病杂志 >糖尿病视网膜病变相关临床和生物化学指标的监测和预警意义

糖尿病视网膜病变相关临床和生物化学指标的监测和预警意义

摘要

Objective To explore the values of different clinical parameters and biochemistry indicators to monitor and predict diabetic retinopathy (DR).Methods The study involved 250 patients with type 2 diabetes mellitua (DM).The patients were divided into DR group (100 patients) with expected sensitivity (Sen) 80%,without DR group (150 patients) with expected specificity (Spe) 60%.DR related clinical and biochemical indicators which including peripheral blood plasma endothelin-1 (ET-1),peripheral vascular endothelial growth factor,plasma magnesium,renal function related indicators,islet function related indicators,blood rheology and blood lipids were detected.Receiver operating characteristic (ROC)was used to analyze accuracy; count the area under a curve (AUC),Sen,Spe and Youden index; develop joint diagnostic testing program.Results The parameters or indicators with clinical value of DR early warning included age,DM duration,plasma ET 1,serum magnesium and urinary albumin (P<0.05).In the period of mild non-progressive DR,plasma ET-1 had the highest diagnostic validity (AUC=0.742,Spe=72.00%,Sen=72.20%) ; in moderate and severe non-progressive DR period,urinary albumin had the highest diagnosis validity (AUC=0.742,Spe=56.10%,Sen=87.88%) ; in the progressive DR period,the diagnostic validity of plasma ET-1 was highest (AUC =0.857,Spe =84.00 %,Sen =85.71%).The joint program with the highest Youden index was DM duration combined with plasma ET-1 serial test,and the early warning value was that DM duration exceeded 3.5 years and the tested plasma ET-1 was greater than 160.00 pg/ml.Conclusions Age,DM duration,plasma ET-1,serum magnesium and urinary albumin are the significant parameters or indicators for DR early warning.Joint diagnostic tests can help patients to monitor the progression of DR.%目的 探讨糖尿病视网膜病变(DR)相关临床和生物化学指标在其监测和预警中的意义.方法 研究对象为2型糖尿病(DM)人群.荧光素眼底血管造影(FFA)作为分组金标准:按预期灵敏度(Sen)为80%收集DR病例组100例,预期特异度(Spe)为60%收集无DR对照组150例.检测研究对象DR相关临床及外周血浆内皮素1(ET-1)、血管内皮生长因子、血镁、肾功能相关指标、胰岛功能相关指标、血液流变学指标、血脂等生物化学指标,运用受试者工作特征(ROC)方法进行准确度比较和分析,计算ROC曲线下面积(AUC)、Sen、Spe和约登指数,制定联合诊断试验方案.结果 ROC曲线分析显示,有DR临床预警价值的指标是年龄、DM病程、血浆ET-1、血镁和尿白蛋白(P<0.05).预管指标诊断准确度分析显示,在轻度非增生型DR时期,血浆ET-1诊断效力最高,AUC=0.742,Spe=72.00%,Sen=72.20%;在中重度非增生型DR时期,尿白蛋白诊断效力最高,AUC=0.742,Spe=56.10%,Sen=87.88%;在增生型DR时期,血浆ET-1诊断效力最高,AUC=0.857,Spe=84.00%,Sen=85.71%.约登指数最高的联合方案是DM病程联合血浆ET-1的序列试验,预警值为DM病程>3.5年和血浆ET-1>160.00 pg/ml.结论 DM患者的年龄、病程、血浆ET-1、血镁和尿白蛋白是临床监测和预警DR的有意义指标.综合利用这些指标制定联合诊断试验可以帮助DM患者进行DR病情的监测和风险评估.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号